• Latest Posts

Cannabinoids in Focus after GW Pharmaceuticals Snapped up for €6B

UK Loosens Controls on GW’s Cannabinoid Epilepsy Drug

More News! 8 Oct 2018

Cannabinoid Drugs Company Raises $300M in Public Offering

Update: The FDA Approves First Cannabinoid Treatment for Epilepsy

GW Pharma’s Latest Cannabinoid Drug Pegged Back by a Placebo in Phase II

Yet More Good News for GW Pharma’s Cannabinoid Drug Against Epilepsy


Signed, Sealed. Will GW Pharma’s Epilepsy Treatment Be a 2018 Blockbuster?

More News! 9 Aug 2017

UK Cannabinoid Company Loses 9% and a Competitor after American Phase II Failure

More News! 29 Mar 2017

More “FDA Love” for Cannabis Company with Orphan Drug Designation

Cannabinoid Drug Prolongs the Life of Brain Tumor Patients in Phase II Trials